title: Management of thrombotic thrombocytopenic purpura in metastatic prostate cancer with only endocrine therapy.
authors.forename: Ravindran
authors.initials: R
authors.lastname: Kanesvaran
authors.forename: Colin
authors.initials: C
authors.lastname: Phipps
authors.forename: Christopher W S
authors.initials: CW
authors.lastname: Cheng
authors.forename: Michelle M F
authors.initials: MM
authors.lastname: Chan
authors.forename: Daphne
authors.initials: D
authors.lastname: Khoo
authors.forename: Min Han
authors.initials: MH
authors.lastname: Tan
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D000813:Anilides / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000150:complications* / Q000556:secondary; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000150:complications* / Q000188:drug therapy*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy* / Q000209:etiology*; D014105:Tosyl Compounds / Q000627:therapeutic use*
chemical_list: D000726:Androgen Antagonists; D000813:Anilides; D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014105:Tosyl Compounds; D017273:Goserelin; C053541:bicalutamide